We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Insulin Detemir and Waist Circumference

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00714844
First Posted: July 14, 2008
Last Update Posted: July 14, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Roma La Sapienza
  Purpose
The purpose of the study is to investigate the weight-sparing effect of detemir and assess glycemic control and treatment satisfaction when switching from NPH to detemir, to improve metabolic control.

Condition
Type 2 Diabetes

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Waist Circumference Reduction After Insulin Detemir Treatment in Type 2 Diabetes Patients Previously Treated With NPH Insulin

Resource links provided by NLM:


Further study details as provided by University of Roma La Sapienza:

Enrollment: 20
Study Start Date: January 2007
Study Completion Date: October 2007
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Type 2 diabetic patients accessing the Diabetologic Centre
Criteria

Inclusion Criteria:

  • Duration of type 2 diabetes for at least 12 months
  • BMI <40 kg/m2
  • HbA1c >7.5%
  • Requiring basal insulin replacement and previously treated with NPH insulin
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Susanna Morano, University of Roma La Sapienza, Policlinico Umberto I, Dpt Scienze Cliniche
ClinicalTrials.gov Identifier: NCT00714844     History of Changes
Other Study ID Numbers: PolUmbI-DptSClin-Det1
First Submitted: July 7, 2008
First Posted: July 14, 2008
Last Update Posted: July 14, 2008
Last Verified: April 2008

Keywords provided by University of Roma La Sapienza:
insulin therapy
insulin detemir
waist circumference

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Insulin, Globin Zinc
Insulin
Insulin Detemir
Hypoglycemic Agents
Physiological Effects of Drugs